SLC25A24 as a novel susceptibility Gene for low fat mass in humans and mice

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 4, 2015, Pages E655-E663

  Urano, Tomohiko ^a   Shiraki, Masataka ^b   Sasaki, Noriko ^a   Ouchi, Yasuyoshi ^a   Inoue, Satoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b RESEARCH INSTITUTE AND PRACTICE FOR INVOLUTIONAL DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ADIPOGENESIS; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CELL DIFFERENTIATION; CONTROLLED STUDY; FAT MASS; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; JAPANESE (PEOPLE); MOUSE; NONHUMAN; OBESITY; OBSERVATIONAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROADIPOCYTE; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SLC25A24 GENE; WHITE ADIPOSE TISSUE; 3T3 CELL LINE; ADIPOSE TISSUE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; GENETIC PREDISPOSITION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ANIMALIA; MUS;

ANTIPORTER; CALCIUM BINDING PROTEIN; CARRIER PROTEIN; MITOCHONDRIAL PROTEIN; SCAMC-1LIKE PROTEIN, MOUSE; SLC25A24 PROTEIN, HUMAN;

3T3-L1 CELLS; ADIPOGENESIS; ADIPOSE TISSUE; ADIPOSITY; AGED; ANIMALS; ANTIPORTERS; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84927609257     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2829     Document Type: Article

References (39)

1. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
2. Lewis CE, McTigue KM, Burke LE, et al. Mortality, health outcomes, and body mass index in the overweight range: A science advisory from the American Heart Association. Circulation. 2009;119:3263-3271.
3. Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA. 1986;256:51-54.
4. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 1997;27:325-351.
5. Pollex RL, Hegele RA. Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med. 2006;3:482-489.
6. Adamski J. Genome-wide association studies with metabolomics. Genome Med. 2012;4:34.
7. Lu Y, Loos RJ. Obesity genomics: Assessing the transferability of susceptibility loci across diverse populations. Genome Med. 2013;5:55.
8. Kilpeläinen TO, Zillikens MC, Stančákova A, et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet. 2011;43:753-760.
9. Berndt SI, Gustafsson S, Mägi R, et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet. 2013;45:501-512.
10. Basile KJ, Johnson ME, Xia Q, Grant SF. Genetic Susceptibility to type 2 diabetes and obesity: Follow-up of findings from genomewide association studies. Int J Endocrinol. 2014;2014:769671.
11. Okada Y, Kubo M, Ohmiya H, et al. Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations. Nat Genet. 2012;44:302-306.
12. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716-723.
13. Hackett CA, Weller JI. Genetic mapping of quantitative trait loci for traits with ordinal distributions. Biometrics. 1995;51:1252-1263.
14. Thomas L. Retrospective power analysis. Conservation Biology. 1997;11:276-280.
15. Ball RD. Experimental designs for robust detection of effects in genome-wide case-control studies. Genetics. 2011;189:1497-1514.
16. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
17. Tchkonia T, Giorgadze N, Pirtskhalava T, et al. Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes. 2006;55:2571-2578.
18. Urano T, Shiraki M, Usui T, Sasaki N, Ouchi Y, Inoue S. Identification of non-synonymous polymorphisms in the WDSOF1 gene as novel susceptibility markers for low bone mineral density in Japanese postmenopausal women. Bone. 2010;47:636-642.
19. Urano T, Shiraki M, Yagi H, et al. GPR98/Gpr98 gene is involved in the regulation of human and mouse bone mineral density. J Clin Endocrinol Metab. 2012;97:E565-E574.
20. Tokuhiro S, Yamada R, Chang X, et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet. 2003;35:341-348.
21. Mangino M, Brouilette S, Braund P, et al. A regulatory SNP of the BICD1 gene contributes to telomere length variation in humans. Hum Mol Genet. 2008;17:2518-2523.
22. Tung YC, Yeo GS, O'Rahilly S, Coll AP. Obesity and FTO: Changing focus at a complex locus. Cell Metab. 2014;20:710-718.
23. Dick KJ, Nelson CP, Tsaprouni L, et al. DNAmethylationandbody-mass index: A genome-wide analysis. Lancet. 2014. 2014;383:1990-1998.
24. del Arco A, Satrústegui J. Identification of a novel human subfamily of mitochondrial carriers with calcium-binding domains. J Biol Chem. 2004;279:24701-24713.
25. Fiermonte G, DeLeonardis F, Todisco S, Palmieri L, Lasorsa FM, Palmieri F. Identification of the mitochondrial ATP-Mg/Pi transporter. Bacterial expression, reconstitution, functional characterization, and tissue distribution. J Biol Chem. 2004;279:30722-30730.
26. Kadowaki T, Yamauchi T, Waki H, Iwabu M, Okada-Iwabu M, Nakamura M. Adiponectin, adiponectin receptors, and epigenetic regulation of adipogenesis. Cold Spring Harb Symp Quant Biol. 2011;76:257-265.
27. Floyd ZE, Stephens JM. Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ. Biochim Biophys Acta. 2012;1822:1090-1095.
28. Musri MM, Párrizas M. Epigenetic regulation of adipogenesis. Curr Opin Clin Nutr Metab Care. 2012;15:342-349.
29. Aprille JR. Regulation of the mitochondrial adenine nucleotide pool size in liver: mechanism and metabolic role. FASEB J. 1988;2:2547-2556.
30. Joyal JL, Aprille JR. The ATP-Mg/Pi carrier of rat liver mitochondria catalyzes a divalent electroneutral exchange. J Biol Chem. 1992;267:19198-19203.
31. Haynes RC Jr, Picking RA, Zaks WJ. Control of mitochondrial content of adenine nucleotides by submicromolar calcium concentrations and its relationship to hormonal effects. J Biol Chem. 1986;261:16121-16125.
32. Nosek MT, Dransfield DT, Aprille JR. Calcium stimulates ATPMg/Pi carrier activity in rat liver mitochondria. J Biol Chem. 1990;265:8444-8450.
33. Pollak JK, Sutton R. The transport and accumulation of adenine nucleotides during mitochondrial biogenesis. Biochem J. 1980;192:75-83.
34. Kunji ER. The role and structure of mitochondrial carriers. FEBS Lett. 2004;564:239-244.
35. Palmieri F. The mitochondrial transporter family (SLC25): Physiological and pathological implications. Pflugers Arch. 2004;447:689-709.
36. Traba J, Satrústegui J, del Arco A. Characterization of SCaMC-3-like/slc25a41, a novel calcium-independent mitochondrial ATPMg/Pi carrier. Biochem J. 2009;418:125-133.
37. Traba J, Del Arco A, Duchen MR, Szabadkai G, Satrústegui J. SCaMC-1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP/ADP-mediated matrix Ca (2+) buffering. Cell Death Differ. 2012;19:650-660.
38. Anunciado-Koza RP, Zhang J, Ukropec J, et al. Inactivation of the mitochondrial carrier SLC25A25 (ATP-Mg2+/Pi transporter) reduces physical endurance and metabolic efficiency in mice. J Biol Chem. 2011;286:11659-11671.
39. Amigo I, Traba J, González-Barroso MM, et al. Glucagon regulation of oxidative phosphorylation requires an increase in matrix adenine nucleotide content through Ca2+ activation of the mitochondrial ATP-Mg/Pi carrier SCaMC-3. J Biol Chem. 2013;288:7791-7802.